BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19555568)

  • 1. [Clinical manifestations, laboratory test, treatment and outcome of neuropsychiatric involvement in pediatric systemic lupus erythematosus patients].
    Wu XY; Song HM; Zeng XF; He YY; Wang W; Li F; Guo YZ; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):286-90. PubMed ID: 19555568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
    Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
    Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.
    Zhou HQ; Zhang FC; Tian XP; Leng XM; Lu JJ; Zhao Y; Tang FL; Zhang X; Zeng XF; Zhang ZL; Zhang W; Dong Y
    Lupus; 2008 Feb; 17(2):93-9. PubMed ID: 18250131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric manifestations in systemic lupus erythematosus and the treatment of intrathecal methotrexate plus dexamethasone].
    Zhou HQ; Leng XM; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):771-4. PubMed ID: 16681954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
    Wang J; Zhao Y; Zhang J; Lei H; Zhu G; Fu B
    Cell Biochem Biophys; 2014 Nov; 70(2):1005-9. PubMed ID: 24845150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
    Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
    Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE.
    Nie Y; Sun B; He X; Zheng M; Wu D; Yang Y; Zhang L; Bai W; Jiang N; Qiao L; Huang C; Zhou S; Zhou J; Peng L; Niu J; Li M; Zhao Y; Zeng X; Wang L; Zhang W
    Arthritis Res Ther; 2023 Mar; 25(1):50. PubMed ID: 36978144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    Wang HP; Wang CY; Pan ZL; Zhao JY; Zhao B
    Chin Med J (Engl); 2016 Mar; 129(5):542-8. PubMed ID: 26904988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
    J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Ikeda S
    Clin Rheumatol; 2005 Sep; 24(5):469-75. PubMed ID: 15742121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes.
    Lim SC; Md-Yusof YL; Johari B; Abdul-Kadir RF; Tang SP
    Turk J Pediatr; 2021; 63(5):743-751. PubMed ID: 34738356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.